{"pmid":32405834,"title":"[COVID-19 cluster study at a teaching hospital].","text":["[COVID-19 cluster study at a teaching hospital].","On Mar 11th, 2020, the World Health Organization (WHO) stated in its Situation Report - 51 Coronavirus disease 2019 (COVID-19) as a pandemic. In early April 2020, a teaching hospital underwent shutdown and quarantine due to an outbreak of infection in accordance with Section 6 of the Infection Protection Act (index patient and 5 infected nursing staff). The complete staff (physicians, nurses and nonmedical personnel [NMP]) underwent COVID-19 testing within two phases: (1) between Apr 3rd and 5th, 2020 [n=1170], followed by (2) between Apr 8th and 9th, 2020 [n=953] with COVID-19 silent carrier positivity rates in accordance to testing phases of (1) n=19 (1.6%) and (2) n=25 (2.6%). The cumulative infection rate for NMP (1.6%), doctors (3.8%) and nurses (9.7%) was connected to type and extent of COVID-19 patient contact. Despite COVID-19 positivity of 34.8% (46 of 132 beds), a risk-free management of hospital operation is possible to a certain extent if hygiene regulations and strict patient selection are followed. However, a COVID-19-free clinic cannot be expected due to silent carriers.","MMW Fortschr Med","von Freyburg, Alexander","Hagedorn, Hjalmar","Brucher, Bjorn","Schmidt, Annette","Scherer, Michael A","32405834"],"abstract":["On Mar 11th, 2020, the World Health Organization (WHO) stated in its Situation Report - 51 Coronavirus disease 2019 (COVID-19) as a pandemic. In early April 2020, a teaching hospital underwent shutdown and quarantine due to an outbreak of infection in accordance with Section 6 of the Infection Protection Act (index patient and 5 infected nursing staff). The complete staff (physicians, nurses and nonmedical personnel [NMP]) underwent COVID-19 testing within two phases: (1) between Apr 3rd and 5th, 2020 [n=1170], followed by (2) between Apr 8th and 9th, 2020 [n=953] with COVID-19 silent carrier positivity rates in accordance to testing phases of (1) n=19 (1.6%) and (2) n=25 (2.6%). The cumulative infection rate for NMP (1.6%), doctors (3.8%) and nurses (9.7%) was connected to type and extent of COVID-19 patient contact. Despite COVID-19 positivity of 34.8% (46 of 132 beds), a risk-free management of hospital operation is possible to a certain extent if hygiene regulations and strict patient selection are followed. However, a COVID-19-free clinic cannot be expected due to silent carriers."],"journal":"MMW Fortschr Med","authors":["von Freyburg, Alexander","Hagedorn, Hjalmar","Brucher, Bjorn","Schmidt, Annette","Scherer, Michael A"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32405834","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1007/s15006-020-0482-z","keywords":["covid-19","hospital","healthcare workers","infection rate","silent carrier"],"topics":["Prevention"],"weight":1,"_version_":1666802845496639488,"score":9.490897,"similar":[{"pmid":32321904,"title":"Asymptomatic carriers of COVID-19 as a concern for disease prevention and control: more testing, more follow-up.","text":["Asymptomatic carriers of COVID-19 as a concern for disease prevention and control: more testing, more follow-up.","Following a containment phase of two months, China has transitioned to the mitigation phase. However, China still faces the risk of COVID-19 spreading due to not only to sporadic new cases and imported cases but also asymptomatic carriers. According to daily reports from the National Health Commission of the People's Republic of China from March 31, 2020 to April 7, 2020, the number of new asymptomatic cases reported daily greatly exceeded that of new imported cases. As of 24:00 on April 7, there were a total of 1,095 asymptomatic cases with COVID-19 under medical observation on the Chinese mainland, including 358 imported cases. A growing number of studies have indicated that asymptomatic carriers are infectious to an extent and can potentially transmit COVID-19. At present, China's measures for managing asymptomatic carriers are 14 days of centralized quarantine and observation; in principle, people with two consecutive negative nucleic acid tests (at an interval of at least 24 hours) can be released from quarantine. However, asymptomatic carriers will not be included in confirmed cases unless they develop clinical manifestations while in quarantine. As \"silent spreaders\", asymptomatic carriers warrant attention as part of disease prevention and control. The testing and follow-up of asymptomatic carriers should be expanded to include people in close contact with patients with confirmed COVID-19 and asymptomatic cases, clusters of outbreaks, and key areas and populations with a high risk of infection.","Biosci Trends","Zhang, Jiao","Wu, Shoucai","Xu, Lingzhong","32321904"],"abstract":["Following a containment phase of two months, China has transitioned to the mitigation phase. However, China still faces the risk of COVID-19 spreading due to not only to sporadic new cases and imported cases but also asymptomatic carriers. According to daily reports from the National Health Commission of the People's Republic of China from March 31, 2020 to April 7, 2020, the number of new asymptomatic cases reported daily greatly exceeded that of new imported cases. As of 24:00 on April 7, there were a total of 1,095 asymptomatic cases with COVID-19 under medical observation on the Chinese mainland, including 358 imported cases. A growing number of studies have indicated that asymptomatic carriers are infectious to an extent and can potentially transmit COVID-19. At present, China's measures for managing asymptomatic carriers are 14 days of centralized quarantine and observation; in principle, people with two consecutive negative nucleic acid tests (at an interval of at least 24 hours) can be released from quarantine. However, asymptomatic carriers will not be included in confirmed cases unless they develop clinical manifestations while in quarantine. As \"silent spreaders\", asymptomatic carriers warrant attention as part of disease prevention and control. The testing and follow-up of asymptomatic carriers should be expanded to include people in close contact with patients with confirmed COVID-19 and asymptomatic cases, clusters of outbreaks, and key areas and populations with a high risk of infection."],"journal":"Biosci Trends","authors":["Zhang, Jiao","Wu, Shoucai","Xu, Lingzhong"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32321904","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.5582/bst.2020.03069","keywords":["china","asymptomatic infections","coronavirus disease 2019 (covid-19)"],"locations":["China","China","Chinese","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis","Prevention","Transmission"],"weight":1,"_version_":1666138493838950400,"score":196.78824},{"pmid":32319131,"title":"Successful containment of COVID-19 outbreak in a large maternity and perinatal center while continuing clinical service.","text":["Successful containment of COVID-19 outbreak in a large maternity and perinatal center while continuing clinical service.","With increasing numbers of SARS-CoV-2 infections and COVID-19 patients to be taken care of by the health system, more and more health workers become affected by the disease. It has been reported that right from the beginning of the outbreak in Lombardy up to 20 % of the doctors and nurses became infected. Under these circumstances, the regular operation of health institutions already suffering from a shortage of staff becomes difficult. This has led to complete or partial shutdowns of hospitals, either due to a lack of uninfected personnel or because of uncontrollable chains of infection endangering patients. In one of the largest university perinatal center in Bavaria with more than 3,000 births per year, an outbreak of COVID-19 occurred in March 2020, affecting 36 staff members, including doctors, nurses and midwives. Here, we describe the outbreak and present the measures contributing to the successful containment of the outbreak within three weeks. At the same time, clinical services could be maintained, however, not without deployment of personnel exposed to employees infected with SARS-CoV-2. Apart from massive testing of personnel in predefined phases and increased hygiene measures, including a general obligation to wear surgical face masks, we identified the need to monitor cases of illness across all groups of employees, to ensure social distancing within personnel and to evaluate contacts of clinical personnel outside of the hospital environment, in order to be able to interpret chains of infections and to disrupt them. Overall, only a bundle of measures is needed to contain such an outbreak.","Pediatr Allergy Immunol","Kabesch, Michael","Roth, Samra","Brandstetter, Susanne","Hausler, Sebastian","Juraschko, Eva","Weigl, Marco","Wellmann, Sven","Lang, Thomas","Schmidt, Barbara","Salzberger, Bernd","Ambrosch, Andreas","32319131"],"abstract":["With increasing numbers of SARS-CoV-2 infections and COVID-19 patients to be taken care of by the health system, more and more health workers become affected by the disease. It has been reported that right from the beginning of the outbreak in Lombardy up to 20 % of the doctors and nurses became infected. Under these circumstances, the regular operation of health institutions already suffering from a shortage of staff becomes difficult. This has led to complete or partial shutdowns of hospitals, either due to a lack of uninfected personnel or because of uncontrollable chains of infection endangering patients. In one of the largest university perinatal center in Bavaria with more than 3,000 births per year, an outbreak of COVID-19 occurred in March 2020, affecting 36 staff members, including doctors, nurses and midwives. Here, we describe the outbreak and present the measures contributing to the successful containment of the outbreak within three weeks. At the same time, clinical services could be maintained, however, not without deployment of personnel exposed to employees infected with SARS-CoV-2. Apart from massive testing of personnel in predefined phases and increased hygiene measures, including a general obligation to wear surgical face masks, we identified the need to monitor cases of illness across all groups of employees, to ensure social distancing within personnel and to evaluate contacts of clinical personnel outside of the hospital environment, in order to be able to interpret chains of infections and to disrupt them. Overall, only a bundle of measures is needed to contain such an outbreak."],"journal":"Pediatr Allergy Immunol","authors":["Kabesch, Michael","Roth, Samra","Brandstetter, Susanne","Hausler, Sebastian","Juraschko, Eva","Weigl, Marco","Wellmann, Sven","Lang, Thomas","Schmidt, Barbara","Salzberger, Bernd","Ambrosch, Andreas"],"date":"2020-04-23T11:00:00Z","year":2020,"_id":"32319131","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1111/pai.13265","locations":["Lombardy","Bavaria"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Prevention"],"weight":1,"_version_":1666138493641818112,"score":196.1149},{"pmid":32271726,"pmcid":"PMC7147909","title":"Detection of SARS-CoV-2 Among Residents and Staff Members of an Independent and Assisted Living Community for Older Adults - Seattle, Washington, 2020.","text":["Detection of SARS-CoV-2 Among Residents and Staff Members of an Independent and Assisted Living Community for Older Adults - Seattle, Washington, 2020.","In the Seattle, Washington metropolitan area, where the first case of novel coronavirus 2019 disease (COVID-19) in the United States was reported (1), a community-level outbreak is ongoing with evidence of rapid spread and high morbidity and mortality among older adults in long-term care skilled nursing facilities (SNFs) (2,3). However, COVID-19 morbidity among residents of senior independent and assisted living communities, in which residents do not live as closely together as do residents in SNFs and do not require skilled nursing services, has not been described. During March 5-9, 2020, two residents of a senior independent and assisted living community in Seattle (facility 1) were hospitalized with confirmed COVID-19 infection; on March 6, social distancing and other preventive measures were implemented in the community. UW Medicine (the health system linked to the University of Washington), Public Health - Seattle & King County, and CDC conducted an investigation at the facility. On March 10, all residents and staff members at facility 1 were tested for SARS-CoV-2, the virus that causes COVID-19, and asked to complete a questionnaire about their symptoms; all residents were tested again 7 days later. Among 142 residents and staff members tested during the initial phase, three of 80 residents (3.8%) and two of 62 staff members (3.2%) had positive test results. The three residents had no symptoms at the time of testing, although one reported an earlier cough that had resolved. A fourth resident, who had negative test results in the initial phase, had positive test results 7 days later. This resident was asymptomatic on both days. Possible explanations for so few cases of COVID-19 in this residential community compared with those in several Seattle SNFs with high morbidity and mortality include more social distancing among residents and less contact with health care providers. In addition, early implementation of stringent isolation and protective measures after identification of two COVID-19 cases might have been effective in minimizing spread of the virus in this type of setting. When investigating a potential outbreak of COVID-19 in senior independent and assisted living communities, symptom screening is unlikely to be sufficient to identify all persons infected with SARS-CoV-2. Adherence to CDC guidance to prevent COVID-19 transmission in senior independent and assisted living communities (4) could be instrumental in preventing a facility outbreak.","MMWR Morb Mortal Wkly Rep","Roxby, Alison C","Greninger, Alexander L","Hatfield, Kelly M","Lynch, John B","Dellit, Timothy H","James, Allison","Taylor, Joanne","Page, Libby C","Kimball, Anne","Arons, Melissa","Schieve, Laura A","Munanga, Albert","Stone, Nimalie","Jernigan, John A","Reddy, Sujan C","Lewis, James","Cohen, Seth A","Jerome, Keith R","Duchin, Jeffrey S","Neme, Santiago","32271726"],"abstract":["In the Seattle, Washington metropolitan area, where the first case of novel coronavirus 2019 disease (COVID-19) in the United States was reported (1), a community-level outbreak is ongoing with evidence of rapid spread and high morbidity and mortality among older adults in long-term care skilled nursing facilities (SNFs) (2,3). However, COVID-19 morbidity among residents of senior independent and assisted living communities, in which residents do not live as closely together as do residents in SNFs and do not require skilled nursing services, has not been described. During March 5-9, 2020, two residents of a senior independent and assisted living community in Seattle (facility 1) were hospitalized with confirmed COVID-19 infection; on March 6, social distancing and other preventive measures were implemented in the community. UW Medicine (the health system linked to the University of Washington), Public Health - Seattle & King County, and CDC conducted an investigation at the facility. On March 10, all residents and staff members at facility 1 were tested for SARS-CoV-2, the virus that causes COVID-19, and asked to complete a questionnaire about their symptoms; all residents were tested again 7 days later. Among 142 residents and staff members tested during the initial phase, three of 80 residents (3.8%) and two of 62 staff members (3.2%) had positive test results. The three residents had no symptoms at the time of testing, although one reported an earlier cough that had resolved. A fourth resident, who had negative test results in the initial phase, had positive test results 7 days later. This resident was asymptomatic on both days. Possible explanations for so few cases of COVID-19 in this residential community compared with those in several Seattle SNFs with high morbidity and mortality include more social distancing among residents and less contact with health care providers. In addition, early implementation of stringent isolation and protective measures after identification of two COVID-19 cases might have been effective in minimizing spread of the virus in this type of setting. When investigating a potential outbreak of COVID-19 in senior independent and assisted living communities, symptom screening is unlikely to be sufficient to identify all persons infected with SARS-CoV-2. Adherence to CDC guidance to prevent COVID-19 transmission in senior independent and assisted living communities (4) could be instrumental in preventing a facility outbreak."],"journal":"MMWR Morb Mortal Wkly Rep","authors":["Roxby, Alison C","Greninger, Alexander L","Hatfield, Kelly M","Lynch, John B","Dellit, Timothy H","James, Allison","Taylor, Joanne","Page, Libby C","Kimball, Anne","Arons, Melissa","Schieve, Laura A","Munanga, Albert","Stone, Nimalie","Jernigan, John A","Reddy, Sujan C","Lewis, James","Cohen, Seth A","Jerome, Keith R","Duchin, Jeffrey S","Neme, Santiago"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32271726","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.15585/mmwr.mm6914e2","locations":["Seattle","Washington","United States","Seattle","Seattle","Washington"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Diagnosis","Transmission","Prevention"],"weight":1,"_version_":1666138491774304256,"score":162.9645},{"pmid":32404482,"title":"Bacteremia and Blood Culture Utilization During COVID-19 Surge in New York City.","text":["Bacteremia and Blood Culture Utilization During COVID-19 Surge in New York City.","A surge of patients with coronavirus disease 2019 (COVID-19) presenting to New York City hospitals in March 2020 led to a sharp increase blood culture utilization, which overwhelmed the capacity of automated blood culture instruments. We sought to evaluate the utilization and diagnostic yield of blood cultures during the COVID-19 pandemic to determine prevalence and common etiologies of bacteremia, and to inform a diagnostic approach to relieve blood culture overutilization. We performed a retrospective cohort analysis of 88,201 blood cultures from 28,011 patients at a multicenter network of hospitals within New York City to evaluate order volume, positivity rate, time to positivity, and etiologies of positive cultures in COVID-19. Ordering volume increased by 34.8% in the second half of March 2020 compared to the first half of the month. The rate of bacteremia was significantly lower among COVID-19 patients (3.8%) than COVID-19 negative patients (8.0%) and those not tested (7.1%), p < 0.001. COVID-19 patients had a high proportion of organisms reflective of commensal skin microbiota, reducing the bacteremia rate to 1.6% when excluded. More than 98% of all positive cultures were detected within 4 days of incubation. Bloodstream infections are very rare for COVID-19 patients, which supports the judicious use of blood cultures in the absence of compelling evidence for bacterial co-infection. Clear communication with ordering providers is necessary to prevent overutilization of blood cultures during patient surges, and laboratories should consider shortening the incubation period from 5 days to 4 days, if necessary, to free additional capacity.","J Clin Microbiol","Sepulveda, Jorge","Westblade, Lars F","Whittier, Susan","Satlin, Michael J","Greendyke, William G","Aaron, Justin G","Zucker, Jason","Dietz, Donald","Sobieszczyk, Magdalena","Choi, Justin J","Liu, Dakai","Russell, Sarah","Connelly, Charles","Green, Daniel A","32404482"],"abstract":["A surge of patients with coronavirus disease 2019 (COVID-19) presenting to New York City hospitals in March 2020 led to a sharp increase blood culture utilization, which overwhelmed the capacity of automated blood culture instruments. We sought to evaluate the utilization and diagnostic yield of blood cultures during the COVID-19 pandemic to determine prevalence and common etiologies of bacteremia, and to inform a diagnostic approach to relieve blood culture overutilization. We performed a retrospective cohort analysis of 88,201 blood cultures from 28,011 patients at a multicenter network of hospitals within New York City to evaluate order volume, positivity rate, time to positivity, and etiologies of positive cultures in COVID-19. Ordering volume increased by 34.8% in the second half of March 2020 compared to the first half of the month. The rate of bacteremia was significantly lower among COVID-19 patients (3.8%) than COVID-19 negative patients (8.0%) and those not tested (7.1%), p < 0.001. COVID-19 patients had a high proportion of organisms reflective of commensal skin microbiota, reducing the bacteremia rate to 1.6% when excluded. More than 98% of all positive cultures were detected within 4 days of incubation. Bloodstream infections are very rare for COVID-19 patients, which supports the judicious use of blood cultures in the absence of compelling evidence for bacterial co-infection. Clear communication with ordering providers is necessary to prevent overutilization of blood cultures during patient surges, and laboratories should consider shortening the incubation period from 5 days to 4 days, if necessary, to free additional capacity."],"journal":"J Clin Microbiol","authors":["Sepulveda, Jorge","Westblade, Lars F","Whittier, Susan","Satlin, Michael J","Greendyke, William G","Aaron, Justin G","Zucker, Jason","Dietz, Donald","Sobieszczyk, Magdalena","Choi, Justin J","Liu, Dakai","Russell, Sarah","Connelly, Charles","Green, Daniel A"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32404482","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1128/JCM.00875-20","locations":["New York","New York","New York"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Diagnosis","Prevention"],"weight":1,"_version_":1666950579771932673,"score":161.66191},{"pmid":32444481,"title":"Temporal estimates of case-fatality rate for COVID-19 outbreaks in Canada and the United States.","text":["Temporal estimates of case-fatality rate for COVID-19 outbreaks in Canada and the United States.","BACKGROUND: Estimates of the casefatality rate (CFR) associated with coronavirus disease 2019 (COVID-19) vary widely in different population settings. We sought to estimate and compare the COVID-19 CFR in Canada and the United States while adjusting for 2 potential biases in crude CFR. METHODS: We used the daily incidence of confirmed COVID-19 cases and deaths in Canada and the US from Jan. 31 to Apr. 22, 2020. We applied a statistical method to minimize bias in the crude CFR by accounting for the survival interval as the lag time between disease onset and death, while considering reporting rates of COVID-19 cases less than 50% (95% confidence interval 10%-50%). RESULTS: Using data for confirmed cases in Canada, we estimated the crude CFR to be 4.9% on Apr. 22, 2020, and the adjusted CFR to be 5.5% (credible interval [CrI] 4.9%-6.4%). After we accounted for various reporting rates less than 50%, the adjusted CFR was estimated at 1.6% (CrI 0.7%-3.1%). The US crude CFR was estimated to be 5.4% on Apr. 20, 2020, with an adjusted CFR of 6.1% (CrI 5.4%-6.9%). With reporting rates of less than 50%, the adjusted CFR for the US was 1.78 (CrI 0.8%-3.6%). INTERPRETATION: Our estimates suggest that, if the reporting rate is less than 50%, the adjusted CFR of COVID-19 in Canada is likely to be less than 2%. The CFR estimates for the US were higher than those for Canada, but the adjusted CFR still remained below 2%. Quantification of case reporting can provide a more accurate measure of the virulence and disease burden of severe acute respiratory syndrome coronavirus 2.","CMAJ","Abdollahi, Elaheh","Champredon, David","Langley, Joanne M","Galvani, Alison P","Moghadas, Seyed M","32444481"],"abstract":["BACKGROUND: Estimates of the casefatality rate (CFR) associated with coronavirus disease 2019 (COVID-19) vary widely in different population settings. We sought to estimate and compare the COVID-19 CFR in Canada and the United States while adjusting for 2 potential biases in crude CFR. METHODS: We used the daily incidence of confirmed COVID-19 cases and deaths in Canada and the US from Jan. 31 to Apr. 22, 2020. We applied a statistical method to minimize bias in the crude CFR by accounting for the survival interval as the lag time between disease onset and death, while considering reporting rates of COVID-19 cases less than 50% (95% confidence interval 10%-50%). RESULTS: Using data for confirmed cases in Canada, we estimated the crude CFR to be 4.9% on Apr. 22, 2020, and the adjusted CFR to be 5.5% (credible interval [CrI] 4.9%-6.4%). After we accounted for various reporting rates less than 50%, the adjusted CFR was estimated at 1.6% (CrI 0.7%-3.1%). The US crude CFR was estimated to be 5.4% on Apr. 20, 2020, with an adjusted CFR of 6.1% (CrI 5.4%-6.9%). With reporting rates of less than 50%, the adjusted CFR for the US was 1.78 (CrI 0.8%-3.6%). INTERPRETATION: Our estimates suggest that, if the reporting rate is less than 50%, the adjusted CFR of COVID-19 in Canada is likely to be less than 2%. The CFR estimates for the US were higher than those for Canada, but the adjusted CFR still remained below 2%. Quantification of case reporting can provide a more accurate measure of the virulence and disease burden of severe acute respiratory syndrome coronavirus 2."],"journal":"CMAJ","authors":["Abdollahi, Elaheh","Champredon, David","Langley, Joanne M","Galvani, Alison P","Moghadas, Seyed M"],"date":"2020-05-24T11:00:00Z","year":2020,"_id":"32444481","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1503/cmaj.200711","locations":["Canada","United States","Canada","US","Canada","US","US","Canada","US","Canada","Canada","United States"],"countries":["United States","Canada"],"countries_codes":["USA|United States","CAN|Canada"],"topics":["Epidemic Forecasting"],"weight":1,"_version_":1667600475856306177,"score":161.04898}]}